105 related articles for article (PubMed ID: 1653561)
1. Augmented responsiveness to sympathetic nerve stimulation of isolated vas deferens of diabetic rats.
Wang YT; Takiguchi Y; Uematsu T; Nakashima M
Arch Int Pharmacodyn Ther; 1991; 309():160-9. PubMed ID: 1653561
[TBL] [Abstract][Full Text] [Related]
2. The field-stimulated vas deferens of the streptozotocin-diabetic mouse: effects of prazosin, alpha, beta-methylene ATP, and variation of stimulation parameters.
Kaschube M; Möller-Hartmann H; Zetler G
J Neural Transm; 1989; 77(2-3):171-80. PubMed ID: 2760603
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of AMP-induced inhibition of sympathetic neurotransmission in the isolated vas deferens of the rat and guinea-pig.
Dalziel HH; Sneddon P
Br J Pharmacol; 1988 Jul; 94(3):961-7. PubMed ID: 2846112
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypophysectomy on purinergic and noradrenergic contractility of the rat vas deferens.
Ralevic V; Burnstock G
J Auton Pharmacol; 1996 Aug; 16(4):191-6. PubMed ID: 8953373
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic, purinergic, and cholinergic transmission in the mouse vas deferens: influence of field-stimulation parameters, reserpinization, 6-hydroxydopamine and 4-aminopyridine.
Kaschube M; Zetler G
J Neural Transm; 1989; 76(1):39-53. PubMed ID: 2540260
[TBL] [Abstract][Full Text] [Related]
6. Actions of alpha, beta-methylene ATP and 6-hydroxydopamine on sympathetic neurotransmission in the vas deferens of the guinea-pig, rat and mouse: support for cotransmission.
Allcorn RJ; Cunnane TC; Kirkpatrick K
Br J Pharmacol; 1986 Dec; 89(4):647-59. PubMed ID: 3028548
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants.
Güneş A; Ceylan A; Sarioglu Y; Stefek M; Bauer V; Karasu C;
Fundam Clin Pharmacol; 2005 Feb; 19(1):73-9. PubMed ID: 15660962
[TBL] [Abstract][Full Text] [Related]
8. Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-I from Brazilian scorpion Tityus serrulatus.
Conceição IM; Jurkiewicz A; Fonseca DR; Opperman AR; Freitas TA; Lebrun I; Garcez-do-Carmo L
Br J Pharmacol; 2005 Feb; 144(4):519-27. PubMed ID: 15678093
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of non-adrenergic transmission in the rat vas deferens by prazosin.
Ebong OO; Zar MA
Afr J Med Med Sci; 1987 Jun; 16(2):103-7. PubMed ID: 2821775
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 selectively affects purinergic transmission in guinea pig vas deferens.
Hata F; Kishi I; Saeki K; Takeuchi T; Yagasaki O
Neuropharmacology; 1991 Oct; 30(10):1107-12. PubMed ID: 1661863
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in sympathetic purinergic transmission along the length of the mouse vas deferens.
Knight D; D'Arbe M; Liang S; Phillips WD; Lavidis NA
Synapse; 2003 Mar; 47(3):225-35. PubMed ID: 12494405
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric distribution of purinergic and adrenergic neurotransmission cooperates in the motor activity along the rat vas deferens.
Rohde GC; Venezian E; Huidobro-Toro JP
Neurosci Lett; 1986 Nov; 71(2):197-202. PubMed ID: 3024075
[TBL] [Abstract][Full Text] [Related]
13. Blockade of vasopressor and vas deferens responses by alpha,beta-methylene ATP in the pithed rat.
Bulloch JM; McGrath JC
Br J Pharmacol; 1988 May; 94(1):103-8. PubMed ID: 2900035
[TBL] [Abstract][Full Text] [Related]
14. Effects of streptozotocin-induced diabetes and insulin on calcium responsiveness of the rat vas deferens.
Oztürk Y; Aydin S
Life Sci; 2006 Feb; 78(10):1084-90. PubMed ID: 16154155
[TBL] [Abstract][Full Text] [Related]
15. Increase of angiotensin-converting enzyme activity and peripheral sympathetic dysfunction could contribute to hypertension development in streptozotocin-induced diabetic rats.
Musial DC; da Silva Júnior ED; da Silva RM; Miranda-Ferreira R; Lima-Landman MT; Jurkiewicz A; García AG; Jurkiewicz NH
Diab Vasc Dis Res; 2013 Nov; 10(6):498-504. PubMed ID: 23975725
[TBL] [Abstract][Full Text] [Related]
16. Influence of acidification on biphasic contractile response of guinea pig vas deferens to electrical field stimulation.
Nakanishi H; Matsuoka I; Ono T; Kimura J
Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):293-302. PubMed ID: 9485523
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of calcitonin gene-related peptide on excitation and contraction of smooth muscles of the rat vas deferens.
Goto K; Kimura S; Saito A
J Pharmacol Exp Ther; 1987 May; 241(2):635-41. PubMed ID: 3494840
[TBL] [Abstract][Full Text] [Related]
18. The effects of testosterone or insulin treatment on contractile responses of the rat vas deferens following castration or streptozotocin-induced diabetes mellitus.
Longhurst PA
Gen Pharmacol; 1990; 21(4):427-34. PubMed ID: 2199297
[TBL] [Abstract][Full Text] [Related]
19. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
Burt RP; Chapple CR; Marshall I
Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
[TBL] [Abstract][Full Text] [Related]
20. Effects of alpha,beta-methylene ATP on potentiation of contractions to field stimulation of rat vas deferens by carbachol.
Lee CM; Cheung WT
Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):17-22. PubMed ID: 2816395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
